Ali Stephen R, Dobbs Thomas D, Hutchings Hayley A, Whitaker Iain S
Reconstructive Surgery and Regenerative Medicine Research Group, Institute of Life Sciences, Swansea University Medical School, Swansea; Welsh Centre for Burns and Plastic Surgery Morriston Hospital, Swansea.
Patient and Population Health and Informatics Research, Swansea University Medical School, Swansea, UK.
J Plast Reconstr Aesthet Surg. 2021 Dec;74(12):3335-3340. doi: 10.1016/j.bjps.2021.05.019. Epub 2021 Jun 6.
Multidisciplinary team (MDT) meetings are an integral component of skin cancer service provision, enabling the implementation of evidence-based decisions and standardised patient outcomes.
We sought to evaluate the composition, quoracy and cost of Specialist Skin Cancer Multidisciplinary Teams (SSMDTs) in the United Kingdom (UK) to establish the functionality and financial impact of these meetings.
Cross-sectional design with a national freedom of information request made to 65 NHS trusts in the UK hosting an SSMDT. Detailed information with regard to attendance frequency and core membership from attendance registers was requested. Quoracy was measured against the 2006 National Institute for Health and Care Excellence Cancer Services standard 'Improving outcomes for people with skin tumours including melanoma'. We costed the SSMDT utilising the running time, core membership salaries derived from national pay scales and overhead values provided by trusts.
Out of 58 respondents (89% response rate), only 15 SSMDTs (26%) were quorate by membership. Forty SSMDTs (69%) were quorate by meeting frequency. The main reasons for membership noncompliance was lack of clinical oncology presence. There was a large variation in the cost per patient (µ = £132.68, range: £31.67-£313.10). There was no geographical variation in quoracy or cost between England, Wales, Scotland and Northern Ireland.
多学科团队（MDT）会议是皮肤癌服务提供的一个重要组成部分，有助于实施基于证据的决策并实现标准化的患者治疗结果。
我们旨在评估英国（UK）专科皮肤癌多学科团队（SSMDT）的组成、参会人数达标情况和成本，以确定这些会议的功能和财务影响。
采用横断面设计，向英国65个主办SSMDT的国民健康服务（NHS）信托机构提出全国性信息自由请求。要求从参会登记册中获取有关参会频率和核心成员的详细信息。根据2006年国家卫生与临床优化研究所癌症服务标准“改善包括黑色素瘤在内的皮肤肿瘤患者的治疗结果”来衡量参会人数达标情况。我们利用运行时间、根据国家薪资标准得出的核心成员薪资以及信托机构提供的间接费用价值来计算SSMDT的成本。
在58名受访者（回复率89%）中，只有15个SSMDT（26%）参会人数达标。40个SSMDT（69%）会议频率达标。成员未达标的主要原因是缺乏临床肿瘤学专家。每位患者的成本差异很大（均值=132.68英镑，范围：31.67英镑至313.10英镑）。英格兰、威尔士、苏格兰和北爱尔兰在参会人数达标情况或成本方面没有地域差异。
